Viking Therapeutics Long Term Deferred Assets (Quarterly) Analysis

Viking Therapeutics, Inc. (VKTX)

31.03 -0.07 (-0.23%) USD | NASDAQ | Feb 20, 16:00

31.01 -0.02 (-0.06%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for VKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Pfizer Inc.	Upgrade
Amgen, Inc.	--
Hims & Hers Health, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade